atevirdine has been researched along with didanosine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Campbell, TB; D'Aquila, RT; Eron, JJ; Kuritzkes, DR; Tarpley, WG; Young, RK | 1 |
Borin, MT; DeRemer, M; Driver, MR; Fischl, MA; Lee, K; Morse, GD; Shelton, MJ; Wajszczuk, CP | 1 |
1 trial(s) available for atevirdine and didanosine
Article | Year |
---|---|
Didanosine reduces atevirdine absorption in subjects with human immunodeficiency virus infections.
Topics: Adolescent; Adult; Antiviral Agents; Cross-Over Studies; Didanosine; Drug Interactions; Female; Half-Life; HIV Infections; HIV-1; Humans; Intestinal Absorption; Male; Middle Aged; Piperazines | 1996 |
1 other study(ies) available for atevirdine and didanosine
Article | Year |
---|---|
Inhibition of human immunodeficiency virus type 1 replication in vitro by the bisheteroarylpiperazine atevirdine (U-87201E) in combination with zidovudine or didanosine.
Topics: Antiviral Agents; Cells, Cultured; Didanosine; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Piperazines; Reverse Transcriptase Inhibitors; Virus Replication; Zidovudine | 1993 |